Malassezia (genus)

Malassezia comprises lipophilic basidiomycete yeasts that form the dominant fungal component of the human skin microbiome, accounting for the large majority of fungal sequence reads in sebaceous body sites in adults ¹. Unlike most fungi, Malassezia has undergone dramatic genome reduction — including complete loss of the fatty acid synthase (FAS) gene — making it obligately dependent on exogenous host lipids for survival ¹ ². The genus colonizes sebaceous-rich skin (scalp, face, upper chest, upper back) where sebum provides the requisite lipid substrates. While commensal at baseline, overgrowth of certain Malassezia species drives common dermatological conditions (seborrheic dermatitis, dandruff, pityriasis versicolor, Malassezia folliculitis) through a combination of host lipid processing, pro-inflammatory metabolite release, and immune dysregulation. In the context of skin aging, Malassezia abundance tracks sebum production — declining after menopause — while seborrheic dermatitis prevalence peaks again in elderly adults, driven by immunosenescence rather than increased fungal load per se. An emerging line of evidence links altered Malassezia composition to Parkinson’s disease skin changes ³.

Identity and taxonomy

Field	Value
Genus	Malassezia Baillon 1889
NCBI Taxonomy ID	55193
Kingdom	Fungi
Phylum	Basidiomycota
Subphylum	Ustilaginomycotina
Class	Malasseziomycetes
Order	Malasseziales
Family	Malasseziaceae
Gram stain	Not applicable (eukaryote)
Morphology	Oval to flask-shaped yeasts; unipolar budding on a broad base; non-spore-forming
Oxygen tolerance	Aerobic
Lipid dependence	Obligate (all species except M. pachydermatis) ⁴

The genus name commemorates Louis-Charles Malassez (1842–1909), who described spore-like bodies in dandruff lesions in 1874; the formal genus was erected by Baillon in 1889. Earlier synonymy includes Pityrosporum (Sabouraud 1904), a name still occasionally seen in older dermatological literature ⁴.

Species diversity

Approximately 19 recognized species as of current NCBI Taxonomy classification (genus is under continuous revision; count was 18–21 in earlier sources). The major human-associated species are:

Species	Human relevance	Body-site preference
M. restricta	Most abundant on human scalp	Scalp (predominant); forehead
M. globosa	Second most abundant; dandruff-dominant	Back, chest, face
M. sympodialis	Common; atopic dermatitis association	Face, arms
M. furfur	Pityriasis versicolor; Malassezia folliculitis	Trunk; systemic in neonates
M. dermatis	Atopic dermatitis association	Face
M. slooffiae	Less-studied; Parkinson’s association signal	Various
M. pachydermatis	Only non-lipid-dependent species; dog-dominant	External ear canal (animals)
M. obtusa, M. japonica, M. nana	Rare/human-isolated	Various

M. restricta and M. globosa together account for the large majority of Malassezia sequence reads from adult human skin across most studies ¹ ⁴ ⁵. A page-level genus treatment is appropriate because these species share the same metabolic niche, ecological context, and aging-relevance; per-species mechanistic differences are in specialized mycology literature.

Ecology and lipid dependence

Genome reduction and lipid auxotrophy

The M. globosa genome (~9 Mb assembled; CBS 7966 strain) is markedly smaller than typical basidiomycetes (~50 Mb) and contains only 4,285 predicted protein-coding genes. The fatty acid synthase (FAS) gene is absent, explaining obligate lipid dependence ¹. Metabolic modeling across M. globosa, M. sympodialis, and M. pachydermatis confirmed that most species lack the genes required for de novo fatty acid synthesis, with the sole exception of the fully lipid-independent M. pachydermatis ². To compensate, Malassezia encodes a battery of secreted lipases (14 lipase genes in M. globosa, 13 of which are predicted secreted) and phospholipases that hydrolyze sebum triglycerides and phospholipids, releasing free fatty acids for assimilation ¹ ⁴.

Lipase activity and metabolite production

Malassezia lipases act on host sebum to generate:

Oleic acid and other unsaturated free fatty acids — penetrate into the skin surface and disrupt the stratum corneum’s tight-junction equivalents, increasing permeability; the major pro-inflammatory metabolite in dandruff and seborrheic dermatitis ⁴
Azelaic acid — a dicarboxylic acid with mild antifungal, antibacterial, and anti-inflammatory properties (the basis for topical azelaic acid as a cosmetic ingredient); biosynthesized via beta-oxidation of host-derived oleic acid
Malassezin and indole-related compounds — tryptophan-derived indoles produced by M. furfur activate the aryl hydrocarbon receptor (AhR) in keratinocytes, inducing apoptosis and contributing to the depigmentation in pityriasis versicolor ⁴ needs-replication — molecular characterization of indole-AhR interactions is based on in vitro studies; in vivo human confirmation limited

no-mechanism — the precise cascade from Malassezia lipase products to immune cell activation in seborrheic dermatitis remains incompletely characterized; no single causal metabolite has been established for the full SD phenotype.

Developmental and age-dependent dynamics

Children’s skin hosts diverse fungal communities dominated by environmental fungi and dermatophytes in prepuberty; post-puberty sebaceous gland activation drives a mycobiome convergence toward Malassezia dominance as increased sebum production in adolescence selectively expands lipophilic fungi ⁵. In children (n=14, age <14), M. globosa was the single predominant Malassezia species across all body sites (59–92% of reads at sites where it occurred), whereas adults (n=19, ages 19–33) showed M. restricta predominating at sebaceous head sites and M. globosa at trunk/occipital sites. This pattern reflects the general principle that sebum is the ecological niche determinant, not host age per se.

In adulthood, Malassezia abundance correlates inversely with sebum output:

Peak sebaceous activity (young adulthood): highest Malassezia abundance; first peak of seborrheic dermatitis prevalence
Mid-life: stable colonization
Post-menopause / elderly men and women: sebum production declines → Malassezia abundance falls; however, seborrheic dermatitis prevalence rises again in elderly adults, suggesting the driver shifts from fungal load to host immune status

Kim et al. 2022 (n=61 Korean women; Y-group n=29, ages 19–28; O-group n=32, ages 60–63; cheek and forehead sites) found that older women showed higher mycobiome alpha-diversity; M. restricta was more abundant on cheeks in the younger group and served as a key discriminating taxon between age groups; sebum content and TEWL both decreased significantly in the older group (sebum p<0.001, TEWL p<0.003 on cheeks), consistent with the sebum-ecology model ⁶.

Li et al. 2020 profiled skin microbial communities across age groups and identified Malassezia among the taxa showing age-related changes, noting that the fungal-bacterial interaction network shifts in aging skin; the review contextualizes Malassezia as part of a remodeling ecosystem rather than an isolated change ⁷.

Beneficial commensal functions

In healthy homeostatic conditions, Malassezia contributes to skin health through:

Niche occupancy and competitive exclusion — high-density sebaceous-niche colonization by Malassezia limits establishment of opportunistic dermatophytes (Trichophyton, Candida spp.) in sebaceous zones
Immune education — persistent low-level colonization trains skin-resident T cells; Malassezia induces Th17-type responses (IL-17A/F) via the IL-23 axis in skin-draining lymph nodes; this IL-17 tone is required for ongoing antifungal immune surveillance ⁸
Local metabolite landscape — azelaic acid produced from Malassezia lipase activity contributes mild antimicrobial activity against Cutibacterium acnes (see cutibacterium-acnes), potentially modulating the competitive balance of skin commensals in sebaceous follicles

Pathogenic associations

Seborrheic dermatitis and dandruff

The most prevalent Malassezia-associated condition. Seborrheic dermatitis (SD) affects ~5% of the general adult population and up to 34–83% in immunosuppressed individuals; dandruff is the milder, non-inflammatory form. Mechanistic consensus ⁴:

M. globosa and M. restricta overgrowth in sebaceous-rich areas
Secreted lipases cleave sebum triglycerides → oleic acid release
Oleic acid disrupts skin barrier, triggers keratinocyte inflammation (IL-1α, IL-8), and drives rapid corneocyte turnover (the visible flaking)
Innate immune activation amplifies local cytokine response → erythema, scaling, pruritus

Aging-specific prevalence: SD peaks in young adults (15–40 yr), declines in mid-life, then shows a second prevalence peak in elderly adults (>65 yr) linked to immunosenescence rather than sebum excess ⁹. Parkinson’s disease is a major risk factor for SD at any age (see below). dose-response-unclear — neither the threshold sebum level nor the Malassezia density required to trigger clinical SD is well established; susceptibility is largely governed by host immune tone.

Pityriasis versicolor

Characterized by hypo- or hyper-pigmented macules on trunk and shoulders, caused primarily by M. furfur and M. globosa under conditions of heat, humidity, and occlusion that promote the yeast-to-hyphal transition. The transition form (hyphal/“mycelial” phase) is the pathogenic form; it evades immune recognition more effectively than the yeast phase. Indole metabolites (including malassezin and pityriacitrin) inhibit melanogenesis in keratinocytes, explaining hypopigmentation ⁴.

Malassezia folliculitis

Follicular pustules and papules, primarily on the upper trunk, caused by M. furfur (also M. globosa, M. sympodialis). Follicular occlusion + lipid-rich environment → pathogenic Malassezia overgrowth within follicular infundibulum. Clinically resembles acne vulgaris; failure to respond to antibiotics is a diagnostic clue. Relevant in immunocompromised aging adults (post-organ transplant, long-term corticosteroid use) ⁹.

Malassezia and Parkinson’s disease

An emerging and incompletely characterized association. Han et al. 2023 (n=95: 47 PD patients, 48 controls; University of Bonn; nested PCR of 4 species from sebum swabs) found significantly elevated Malassezia species diversity on the skin of Parkinson’s disease (PD) patients vs age-matched controls (3.5 vs 2.9 species per individual, p=0.002), with M. slooffiae showing OR=9.358 (95% CI 2.931–29.880, p<0.001) for PD association and M. sympodialis prevalence also higher in PD (74.5% vs 54.2%) ³. Note: the study used nested PCR targeting only 4 species (M. restricta, M. globosa, M. slooffiae, M. sympodialis) — not full mycobiome sequencing; this constrains the generalizability of the diversity finding. This finding is:

Consistent with the long-recognized clinical observation that SD is markedly overrepresented in PD patients (~60% of PD patients have SD vs ~5% of general population)
Mechanistically unresolved: PD-associated seborrheic changes may reflect autonomic dysfunction (increased sebum secretion in PD) rather than a direct Malassezia–neurodegeneration link
Potentially relevant as a bidirectional gut-skin-brain axis signal — Malassezia species have also been detected in gut mycobiome studies — but causality is not established

contradictory-evidence — whether altered Malassezia skin composition in PD reflects a cause, consequence, or shared upstream driver (autonomic dysfunction, immune dysregulation) is unresolved. The Han 2023 finding (n=95 total; Frontiers journal; single-center; limited to 4 species by nested PCR) requires independent replication with full mycobiome sequencing. needs-replication

Immune interactions

IL-23 / IL-17 axis (Sparber 2019)

Malassezia colonization drives a type 17 (Th17/IL-17) immune response in mouse skin via IL-23-dependent signaling ⁸. Key findings:

Colonization of mouse skin with M. sympodialis triggered robust IL-17 responses; a CCR6+ Th17 subset of memory T cells was identified as Malassezia-specific in both healthy individuals and atopic dermatitis patients (with enhanced frequency in the latter) — γδ T-cell involvement was described in the mouse model but the abstract does not enumerate strains or n needs-replication for γδ T-cell specifics
Disruption of the IL-23–IL-17 axis via genetic knockout (Il23a⁻/⁻, Il17ra⁻/⁻) impaired antifungal immunity and increased Malassezia skin burden
When skin barrier was disrupted (tape-stripping model), Malassezia dramatically exacerbated cutaneous inflammation; IL-17 was required both for fungal control and for the inflammatory amplification
The same antifungal axis that controls Malassezia also exacerbates atopic dermatitis (AD) when barrier integrity is compromised — relevant to the known AD–Malassezia association

Dimension	Status
Pathway conserved in humans?	partial — IL-17/IL-23 axis is conserved; Malassezia-specific T cell responses documented in human AD patients
Phenotype conserved in humans?	partial — Malassezia decolonization reduces AD severity in some patients; direct SD IL-17 data limited
Replicated in humans?	no — Sparber 2019 findings are mouse-model; human mechanistic studies pending

needs-human-replication — the Sparber 2019 IL-23/IL-17 mechanistic findings are from mouse models; controlled human studies directly measuring this axis in Malassezia-driven skin disease are not yet published.

Aging context

Sebum-Malassezia decline with age

Post-menopausal women and elderly men show reduced sebum production → Malassezia abundance declines on sebaceous body sites. This reduction is a normal skin microbiome aging shift tracked in skin-microbiome-aging-shifts. The clinical consequence is not clearance of Malassezia but a shift in the species balance and spatial distribution of colonization.

Second peak of seborrheic dermatitis in elderly adults

Despite lower sebum and lower Malassezia burden, SD prevalence increases again in the elderly, peaking in adults over 65 ⁹. The proposed driver is cellular-senescence-associated immune dysfunction (immunosenescence): declining IL-17 and Th17 antifungal responses with age allow even low Malassezia loads to elicit disproportionate inflammation through disrupted skin barrier (thinner, drier aged skin) and impaired fungal containment. Complicating factors: institutionalized elderly have higher SD rates; comorbid neurological disease (Parkinson’s, dementia) independently increases SD susceptibility.

Immune-barrier co-decline model

The composite aging-skin susceptibility model:

Aged skin: thinner epidermis, reduced barrier lipids (ceramides, free fatty acids), higher transepidermal water loss
Immunosenescence: reduced Th17 tone, decreased Langerhans cell density and function
Malassezia leverage: even commensal-level Malassezia can trigger disproportionate inflammatory responses through breached barrier → IL-1α → cytokine cascade
Clinical result: SD, chronic facial erythema, pruritus disproportionate to fungal burden

This model is primarily synthesized from the mechanistic literature (Xu 2007, Sparber 2019, Sowell 2022); no single study directly tests the full causal chain in aging humans. no-mechanism

Treatment and interventions

Antifungal management of Malassezia-driven conditions in older adults:

Treatment	Mechanism	Evidence level
Ketoconazole (1–2% shampoo/cream)	Azole: inhibits ergosterol synthesis (CYP51A1)	High (multiple RCTs for SD; gold standard)
Selenium sulfide (1–2.5% shampoo)	Cytostatic + antifungal; exact mechanism unclear	Moderate (established clinical use)
Zinc pyrithione (1–2% shampoo)	Inhibits membrane transport; fungistatic	Moderate; maintenance use; study in ¹⁰
Ciclopirox (0.77% gel/shampoo)	Chelates metal-dependent enzymes; broad antifungal	Moderate
Salicylic acid (2–5% topical)	Keratolytic + mild antifungal; reduces scale	Low; adjunctive (see salicylic-acid R44 sister)
Topical itraconazole / fluconazole	Systemic azoles off-label; oral for recalcitrant SD	Moderate
Cold atmospheric plasma	Emerging physical therapy; RCT for Malassezia folliculitis (Wang 2024, doi:10.1111/srt.13850)	Low; single trial

Topical antifungal treatment does NOT target Malassezia for the purpose of “skin aging” per se — there is no evidence that reducing Malassezia burden modulates hallmarks of skin aging (wrinkle formation, elastin loss, melanocyte changes). Treatment is for symptomatic control of specific Malassezia-driven dermatoses.

long-term-unknown — maintenance antifungal regimens in elderly SD patients have not been studied in controlled trials for quality-of-life or functional outcomes; optimal treatment duration and recurrence-prevention strategies in elderly adults are not established.

Gaps

needs-replication — Han 2023 Malassezia–Parkinson’s disease skin association requires independent replication in larger, multi-center cohorts
needs-human-replication — IL-23/IL-17 antifungal axis (Sparber 2019) characterized in mouse model; direct human mechanistic studies absent
no-mechanism — full causal chain from Malassezia lipase metabolites to seborrheic dermatitis inflammatory cascade not established in human skin
contradictory-evidence — whether increased Malassezia diversity in PD patients reflects cause, consequence, or shared driver (autonomic sebaceous dysregulation) is unresolved
long-term-unknown — no prospective study tracks Malassezia abundance longitudinally across the full human aging trajectory in the same individuals
dose-response-unclear — Malassezia density threshold for SD onset not established; susceptibility governed primarily by host immune tone rather than fungal burden
Wiki stubs needed: skin-microbiome-aging-shifts (R44 sister — may exist; verify), skin-aging, cutibacterium-acnes (R44 sister), staphylococcus-epidermidis (R44 sister), salicylic-acid (R44 sister), epidermis, immunosenescence

Footnotes

xu-2007-malassezia-globosa-genome · doi:10.1073/pnas.0706756104 · in-silico/genomic · model: M. globosa CBS 7966 full genome (~9 Mb assembled; 4,285 protein-coding genes; 14 lipase genes) + partial M. restricta CBS 7877; 7× shotgun coverage · Xu J, Saunders CW, Hu P, Grant RA, Boekhout T et al. · PNAS 2007;104(47):18730–18735 · archive status: downloaded (green OA) ↩ ↩² ↩³ ↩⁴ ↩⁵
triana-2017-malassezia-lipid-metabolic-modeling · doi:10.3389/fmicb.2017.01772 · in-silico (metabolic modeling + proteomics) · model: M. globosa, M. sympodialis, M. pachydermatis · Triana S et al. · Front Microbiol 2017 · 44 citations · archive status: pending download (gold OA) ↩ ↩²
han-2023-malassezia-parkinson-skin · doi:10.3389/fnagi.2023.1268751 · observational (case-control) · model: n=95 (47 PD, 48 controls); sebum swab nested PCR for 4 Malassezia spp. (M. restricta, M. globosa, M. slooffiae, M. sympodialis); single-center (Univ. Bonn) · Han X, Bedarf J, Proske-Schmitz S, Schmitt I, Wüllner U · Front Aging Neurosci 2023;15:1268751 · archive status: downloaded (gold OA) · single-center; limited to 4 species; needs replication ↩ ↩²
dawson-2007-malassezia-dandruff-sebodermatitis · doi:10.1038/sj.jidsymp.5650049 · review · model: M. globosa and M. restricta genomics + clinical dermatology · Dawson TL Jr · J Investig Dermatol Symp Proc 2007 · 198 citations · archive status: pending download (bronze OA) · no-fulltext-access (not_oa locally) ↩ ↩² ↩³ ↩⁴ ↩⁵ ↩⁶ ↩⁷ ↩⁸
jo-2016-skin-fungal-children-adults · doi:10.1016/j.jid.2016.05.130 · observational · model: human skin mycobiome 10 sites (9 skin + nares); children (n=14, age <14; Tanner stage 1–3) vs adults (n=19, ages 19–33) · Jo JH, Deming C, Kennedy EA et al. · J Invest Dermatol 2016;136(12) · archive status: download failed (green OA); full text confirmed via PMC5687974 ↩ ↩²
kim-2022-aged-skin-microbiome-mycobiome-korean · doi:10.1038/s41598-022-06189-5 · observational · model: Korean women n=61 (Y-group n=29, ages 19–28; O-group n=32, ages 60–63); cheek + forehead; 16S rRNA (v4–v5) + ITS (18S F–5.8S 1R) amplicon sequencing · Kim HJ, Oh HN, Park T et al. · Sci Rep 2022 · archive status: downloaded (gold OA) ↩
li-2020-skin-microbial-communities-aging · doi:10.3389/fmicb.2020.565549 · review · model: skin microbiome profiling across age groups; narrative synthesis · Li Z et al. · Front Microbiol 2020 · 77 citations · archive status: pending download (gold OA) ↩
sparber-2019-malassezia-type17-immunity · doi:10.1016/j.chom.2019.02.002 · in-vivo · model: mouse skin colonization; C57BL/6 + Il23a⁻/⁻ + Il17ra⁻/⁻ knockouts; n not specified in abstract · Sparber F, De Gregorio C, Steckholzer S et al. · Cell Host Microbe 2019;25(3):389–403.e6 · 239 citations · archive status: pending download (bronze OA) · no-fulltext-access ↩ ↩²
sowell-2022-seborrheic-dermatitis-older-adults · doi:10.1007/s40266-022-00930-5 · review · model: clinical review of SD in adults ≥65 yr · Sowell J, Pena SM, Elewski BE · Drugs Aging 2022 · 30 citations · archive status: not_oa locally · no-fulltext-access ↩ ↩² ↩³
leong-2021-zinc-pyrithione-malassezia · doi:10.1093/mmy/myaa068 · in-vitro + clinical · model: Malassezia species susceptibility testing + shampoo clinical use · Leong C et al. · Med Mycol 2021 · archive status: pending download ↩

🧬 Aging Wiki

Explorer

malassezia